Nomura rounds up markets’ biggest misses in 2016

Forecasting markets a year in advance is never easy, but with “year-ahead investment themes” season well underway, Nomura has provided a handy reminder of quite how difficult it is, with an overview of markets’ biggest hits and misses (OK, mostly misses) from the start of 2016. The biggest miss among analysts, according to Nomura’s Sam […]

Continue Reading


Spanish construction rebuilds after market collapse

Property developer Olivier Crambade founded Therus Invest in Madrid in 2004 to build offices and retail space. For five years business went quite well, and Therus developed and sold more than €300m of properties. Then Spain’s economy imploded, taking property with it, and Mr Crambade spent six years tending to Dhamma Energy, a solar energy […]

Continue Reading


Euro suffers worst month against the pound since financial crisis

Political risks are still all the rage in the currency markets. The euro has suffered its worst slump against the pound since 2009 in November, as investors hone in on a series of looming battles between eurosceptic populists and establishment parties at the ballot box. The single currency has shed 4.5 per cent against sterling […]

Continue Reading


RBS falls 2% after failing BoE stress test

Royal Bank of Scotland shares have slipped 2 per cent in early trading this morning, after the state-controlled lender emerged as the biggest loser in the Bank of England’s latest round of annual stress tests. The lender has now given regulators a plan to bulk up its capital levels by cutting costs and selling assets, […]

Continue Reading


China capital curbs reflect buyer’s remorse over market reforms

Last year the reformist head of China’s central bank convinced his Communist party bosses to give market forces a bigger say in setting the renminbi’s daily “reference rate” against the US dollar. In return, Zhou Xiaochuan assured his more conservative party colleagues that the redback would finally secure coveted recognition as an official reserve currency […]

Continue Reading

Categorized | Capital Markets

Pace of global debt sales hits record level

Posted on November 18, 2016

The pace of global debt sales this year is running at a record level, surpassing $6tn this week, as companies from Pfizer to MasterCard rush to lock in borrowing costs on fears that a Donald Trump stimulus package will send interest rates even higher.

A flurry of new sales this week caps a tumultuous period for bond investors, who are counting more than $1.5tn of losses, as yields have jumped on sovereign and corporate debt following Mr Trump’s victory last week.

The so-called Trumpflation trade — in which investors are betting Mr Trump and a Republican Congress will stoke inflation and growth through tax cuts and infrastructure spending — has propelled the yield on the benchmark 10-year Treasury 39 basis points higher. Yields rise as bond prices fall.

Money managers and bankers have been watching the sell-off in fixed income assets that are an abrupt reversal from earlier this year, when central bank stimulus helped push yields on more than $13.5tn of bonds below zero. That figure has fallen to $11.8tn, as investors bet that the great bull market in bonds is ending.

“The terms of the debate are changing,” said Nick Gartside, international fixed income chief investment officer at JPMorgan Asset Management. “We’re in this transition from monetary policy being the very big driver of markets to fiscal policy.”

Bond offerings this year are now running at less than 9 per cent below the record of $6.6tn set in 2006, Dealogic data shows. This year’s figure, which includes corporate, country, agency and asset-backed security sales, is up 8 per cent from 2015 and is running 2 per cent above every other year.

The data exclude sovereign bonds sold at auction, such as US Treasuries or British gilts, and municipal offerings.

This week’s sales have included a $15.1bn offering from pharmaceutical group Abbott Laboratories — expected to be the year’s fourth largest when completed on Thursday — a $6bn sale from Pfizer and $2bn offering from MasterCard.

Demand for corporate debt has been tested by the increased rates, as investors fear volatile price swings over the coming months. Mr Gartside noted that, while some money managers were on the sidelines waiting to see “how markets settle down”, the higher yields were attracting pension investors.

A consensus has spread across asset managers that rates have already troughed and will rise further over the next year. Jeffrey Gundlach, the influential bond investor and founder of DoubleLine Capital, said he believed rates had already bottomed.

“This has been an incredibly powerful interest rate move,” he said. “With interest rates rising in the last few months, many people are much less bullish. We have a lot of company in looking for higher interest rates.”

That could entice companies to market that have financing needs sooner, as they try to pin down borrowing costs. The question that remains for many investors is whether indebted groups will add to their burdens to fund investments in plants, equipment and research, or if their focus will remain on share buybacks and dividend payouts.